Validation of a 25-color spectral flow cytometry assay for immunoprofiling of human whole blood samples from clinical trials

Written by ICON plc
Article Clinical Flow Cytometry Immunogenicity

In this article, ICON details the validation and implementation of a 25-color spectral flow cytometry assay for comprehensive immunophenotyping in clinical trials, using the Cytek Aurora 5-laser platform. The article highlights assay performance, reproducibility, stability across various sample types, and its suitability for high-resolution immune monitoring in global clinical studies.

Validation of a 25-colour spectral flow assay FINAL

This feature is part of the Bioanalysis Zone Spotlight on flow cytometry in bioanalysis. For more expert opinions on this topic, visit our feature homepage.

This feature was produced in association with: